A national double-blind clinical trial of a new corticosteroid lotion: a 12-investigator cooperative analysis.
D000433:1-Propanol / Q000009:adverse effects; D000293:Adolescent; D000328:Adult; D000368:Aged; D001623:Betamethasone / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D012628:Dermatitis, Seborrheic / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D014677:Pharmaceutical Vehicles; D010919:Placebos; D011537:Pruritus / Q000139:chemically induced; D011565:Psoriasis / Q000188:drug therapy*; D012535:Scalp; D014631:Valerates / Q000009:adverse effects / Q000627:therapeutic use
D014677:Pharmaceutical Vehicles; D010919:Placebos; D014631:Valerates; D000433:1-Propanol; D001623:Betamethasone